期刊文献+

GnRH-α用于子宫肌瘤术前预处理的疗效观察 被引量:3

下载PDF
导出
作者 马永琴 饶娇
出处 《中国计划生育学杂志》 北大核心 2009年第4期240-240,共1页 Chinese Journal of Family Planning
  • 相关文献

参考文献2

二级参考文献15

  • 1廖爱华.米非司酮的作用机理及临床应用[J].实用妇产科杂志,1994,10(1):15-16. 被引量:532
  • 2吴际,程云英.子宫肌瘤组织雌、孕激素受体及细胞增殖相关抗原与激素及细胞核体关系的探讨[J].中华妇产科杂志,1995,30(10):603-607. 被引量:92
  • 3杨幼林,郑淑蓉,李克敏,张炳兰.两种不同剂量米非司酮治疗子宫肌瘤的疗效观察[J].中华妇产科杂志,1996,31(10):624-626. 被引量:217
  • 4[1]Buttam VCJ,Reiter RC.Uterine leiomyomata:etiology,symptomatology and management.Fertil Steril,1981,36:433
  • 5[2]Vollenhoven BJ,Lawrence AS,Healy DL.Uterine fibroids:a clinical review.Br J Obstet Gynecol,1990,97:258
  • 6[3]Rein Ms,Barbieri RL,Friedman AJ.Progesterone:a critical role in the pathogenesis of uterine myomas.Am J Obstet Gynecol,1995,172:14
  • 7[4]Murphy AA,Kettel LM,Morales AJ,et al.Regression of uterine leiomyoma in response to antiprogestin mifepristone.J Clin Endocrinol Metab,1993,76:513
  • 8[9]Reinsch RC,Murphy AA,Morales AJ,et al.The effects of RU486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus:a prospective,randomized study.Am J Obstet Gynecol,1994,170:1623
  • 9[10]Stovall TG.GnRH-a utilization before hysterectomy.Clin Obstet Gynecol,1993,36:642
  • 10Dueholm M. Forman A, Ingerslev J. Regression of residual tissue after implete resection of submucous myomas. Gynecol Endos 1998,7:309~314.

共引文献216

同被引文献29

  • 1吕华,夏恩兰.GnRHa治疗子宫平滑肌瘤研究进展[J].国外医学(妇产科学分册),2006,33(1):33-36. 被引量:9
  • 2Ludovico Muzii, Terenzio Boni. GnRH analogue treatment before hysteroscopic resection of submucous myomas: A prospective, randomized, multicenter study[J]. Fertil Steri1,2010,94 : 1496-1499.
  • 3夏思兰 FelixWong 李白新.妇科内镜学[M].北京:人民卫生出版社,2001.5..
  • 4Zhang Y, Sun L, Guo Y, et al. The impact of preoperative Gonadotropin-releasing hormone agonist treatment on women with uterine fibroids : a meta- analysis [ J ]. Obstet Gynecol Surv, 2014, 69 (2): 100-108.
  • 5Kim M D, Lee M, Lee M S, et al. Uterine artery embolization of large fibroids: comparative study of procedure with and without pretreatment gonadotropin-releasing hormone agonists [J]. MR Roentgenol, 2012, 199 (2) : 441-446.
  • 6Chu CM, Dabney L, Hardart A. Treatment of urinary retention caused by uterine leiomyoma with a gonadotropin- releasing hormone agonist: case report and review [J]. Female Pelvic Med Reconstr Surg, 2013, 19 (1) : 52-55.
  • 7Bosch E, Labarta E, Crespo J, et al. Impact of luteinizing hormone administration on gonadotropin- releasing hormone antagonist cycles: an age- adjusted analysis [ J]. Fertil Steril, 2011, 95 (3): 1031-1036.
  • 8Talaulikar VS, Manyonda IT. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids [J]. AdvTher, 2012, 29 (8):655-663.
  • 9Jasonni VM, D "Anna R, Mancuso A, et al. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra - operative blood loss of different length of leuprolide acetate depot treatment before myomectomy [J]. Acta Obstet Gynecol Scand, 2001, 80 (10) : 956-958.
  • 10Watanabe Y, Nakamura G, Matsuguchi H, et al. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women [ J]. Fertil Steril, 1992, 58 (1) : 66-71.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部